Solid Tumors

These resources provide a detailed overview of biomarker testing approaches and the importance of biomarker testing in select common solid tumors.

Individualize the Risk of Recurrence in Early Breast Cancer

This resource provides an overview of the risk of recurrence in HR+ eBC, the importance of appropriate risk assessments in HR+/HER2- eBC, and considerations to further individualize risk assessment by combining complementary prognostic information.
Download the Individualize the Risk of Recurrence in Early Breast Cancer Brochure (PDF 3.6 MB)

Getting a Personalized Risk Assessment in Early Breast Cancer – A Patient Journey

This resource provides an overview of a hypothetical patient journey with early breast cancer (eBC), highlighting the important role the multidisciplinary team (MDT) plays when assessing risk, and clinical considerations for treatment decisions in HR+/HER2- eBC.
Download the Getting a Personalized Risk Assessment in Early Breast Cancer – A Patient Journey Case Study (PDF 1.0 MB)

Biomarker Testing in Metastatic Breast Cancer

This resource provides an overview of metastatic breast cancer (mBC), the role of the MDT in biomarker testing, and considerations for sample collection and biomarker testing in mBC.
Download the Biomarker Testing in Metastatic Breast Cancer Brochure (PDF 1.9 MB)

Biomarkers in Advanced and Metastatic Melanoma

This resource provides an overview of predictive and prognostic biomarkers in advanced or metastatic melanoma, as well as guideline recommendations for testing.
Download the Biomarkers in Advanced and Metastatic Melanoma Brochure (PDF 1.1 MB)

The Impact of Pan-Tumor Biomarker Testing

This resource provides an overview of pan-tumor biomarker testing and its importance in identifying therapy options for patients, including discussions of testing in select rare solid tumors, testing in neuro-oncology, and the utility of panel testing for pan-tumor biomarkers.
Download the Impact of Pan-Tumor Biomarker Testing Brochure (PDF 2.4 MB)

The Importance of a Molecular Diagnosis in Metastatic Non–Small Cell Lung Cancer (mNSCLC)

This resource provides an overview of biomarker testing in mNSCLC, the role of the MDT, testing with small samples, next-generation sequencing (NGS), and potential considerations to improve biomarker testing.
Download the Importance of a Molecular Diagnosis in mNSCLC Brochure (PDF 3.0 MB)

Biomarker Testing in Metastatic Breast Cancer Knowledge Checks #1 and #2

This resource provides a quiz and answer key based on the mBC brochure to check your knowledge on material such as biomarker testing in mBC, the role of the MDT, testing with small samples, NGS, and potential considerations to improve biomarker testing.
Download the Biomarker Testing in Metastatic Breast Cancer Knowledge Check #1 (PDF 1.0 MB)
Download the Biomarker Testing in Metastatic Breast Cancer Knowledge Check #2 (PDF 0.5 MB)

The Importance of a Molecular Diagnosis in mNSCLC Knowledge Checks #1 and #2

This resource provides a quiz and an answer key based on the mNSCLC brochure to check your knowledge on materials such as biomarker testing in mNSCLC, the role of the MDT, testing with small samples, NGS, and potential considerations to improve biomarker testing.
Download the Importance of a Molecular Diagnosis in mNSCLC Knowledge Check #1 (PDF 1.7 MB)
Download the Importance of a Molecular Diagnosis in mNSCLC Knowledge Check #2 (PDF 0.5 MB)

Hematology

These resources provide a detailed overview of biomarker testing approaches and challenges for hematologic disorders.

Paroxysmal Nocturnal Hemoglobinuria Laboratory Contact Quick Reference List 

This resource provides a quick reference list for clinical laboratories offering flow cytometry testing along with a brief review of the importance of routing monitoring in PNH. 
Download the Paroxysmal Nocturnal Hemoglobinuria Laboratory Contact Quick Reference List (PDF 3.9 MB)

Paroxysmal Nocturnal Hemoglobinuria 1-Pager for Lab Values

This resource provides a quick reference for checking select lab values related to paroxysmal nocturnal hemoglobinuria (PNH) and a reminder of when to test patients using high-sensitivity flow cytometry.
Download the PNH Lab Values Flashcard (PDF 0.2 MB)

Identifying Paroxysmal Nocturnal Hemoglobinuria With Flow Cytometry

This resource enhances your understanding of PNH and its accurate diagnosis using flow cytometry.
Download the Identifying Paroxysmal Nocturnal Hemoglobinuria With Flow Cytometry Brochure (PDF 0.9 MB)

Understanding Challenges in Hematologic Diagnostics: Paroxysmal Nocturnal Hemoglobinuria

This resource provides a better understanding of the diagnostic challenges in patients with PNH.
Download the Understanding Challenges in Hematologic Diagnostics: Paroxysmal Nocturnal Hemoglobinuria Brochure (PDF 1.0 MB)

The Complement System for Paroxysmal Nocturnal Hemoglobinuria 

This resource provides a quick reference depicting the role of the complement system in PNH along with considerations for routine monitoring. 
Download the Complement System for Paroxysmal Nocturnal Hemoglobinuria 1-Pager (PDF 0.4 MB)

Digital Binder

Here you can find resources to support the entire multidisciplinary team with content specifically designed to address testing challenges; we have assembled our most popular educational brochures and knowledge checks into a Novartis Precision Medicine binder.

Precision Medicine Digital Binder

The digital binder contains the following:

• Essential Elements of Biomarker Testing During the Diagnostic Journey Brochure (PDF 1.3 MB)
• Biomarker Testing Reimbursement Brochure (PDF 0.75 MB)
• Biomarker Testing in Metastatic Breast Cancer Brochure (PDF 1.9 MB)
• The Importance of a Molecular Diagnosis in mNSCLC Brochure (PDF 3.0 MB) 
• Molecular Diagnostics in Personalized Cancer Care Brochure (PDF 1.0 MB)
• The Importance of a Molecular Diagnosis in mNSCLC Knowledge Check #1 and #2 (PDF 1.7 MB); (PDF 0.5 MB)
• Biomarker Testing in Metastatic Breast Cancer Knowledge Check #1 and #2 (PDF 1.0 MB); (PDF 0.5 MB)
• Molecular Diagnostics in Personalized Cancer Care Knowledge Check #1 and #2 (PDF 0.7 MB); (PDF 0.5 MB)
• Molecular Profiling in Common Cancers Brochure (PDF 0.9 MB) 
• The Ins and Outs of Test Requisition Forms Brochure (PDF 1.0 MB)

Download the Precision Medicine Digital Binder (PDF 7.91 MB)

Educational Videos

Here you can find educational videos that cover a range of topics that dive into current state-of-the-art biomarker testing approaches and the importance of biomarker testing. Speakers have been compensated by Novartis Pharmaceuticals Corporation for their time.

The Importance of Comprehensive Biomarker Testing in mNSCLC

VIDEO

What Role Do Pathologists Play in Liquid Biopsies?

VIDEO

What Is Next-Generation Sequencing?

VIDEO

Reading a Liquid Biopsy NGS Report

VIDEO

Liquid Biopsy FDA Approvals

VIDEO

Discover the different types of FDA approvals for liquid biopsy tests and what they mean for your practice.

What Is Liquid Biopsy?

VIDEO

Learn about ctDNA, cfDNA, and the role they play in liquid-based biomarker testing.

When Are Liquid Biopsies Clinically Used?

VIDEO

Find out when liquid biopsy may be an appropriate option for your patients.

What Is Important to Consider When Taking a Liquid Biopsy?

VIDEO

Learn how to obtain and process a sample for liquid biopsy.

Tissue and Liquid Biopsy Concordance 

VIDEO

Find out how biopsy choice can affect biomarker test results.

Risk of False-Positive and False-Negative Results with Liquid Biopsies 

VIDEO

Learn about the accuracy of liquid-based biomarker testing.